- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 28.04. | Innorna secures dual FDA designations for Wilson's disease mRNA therapy | ||
| 28.04. | Merck KGaA strikes $3.9bn deal for SpringWorks | ||
| 28.04. | Amgen to invest $900m in Ohio manufacturing facility | ||
| 28.04. | China approves InnoCare Pharma's BTK inhibitor for lymphoma | ||
| 25.04. | Merck KGaA nears $3.5bn deal for SpringWorks | ||
| 25.04. | FDA free to pursue semaglutide compounders after latest court ruling | ||
| 25.04. | FDA approves Akeso's monoclonal antibody for nasopharyngeal carcinoma | ||
| 25.04. | Caribou cuts pipeline and workforce to focus on lead CAR-T programmes | ||
| 25.04. | Granite Bio secures $100m in funding for new antibodies | ||
| 25.04. | EC grants orphan drug designation to Dyne Therapeutics' DMD therapy | ||
| 24.04. | Pharma companies in Europe push for US-level drug prices | ||
| 24.04. | AstraZeneca enters $200m AI cancer pact with Tempus and Pathos | ||
| 24.04. | Repertoire and Genentech to develop autoimmune disease therapies | ||
| 24.04. | Biogen's Friedreich's ataxia treatment authorised in UK | ||
| 23.04. | Eli Lilly sues Mochi Health and others for 'deceptive' tirzepatide marketing | ||
| 23.04. | Veraxa to go public in $1.6bn SPAC deal with Voyager | ||
| 23.04. | Synthetic hormones and the future of contraception | ||
| 23.04. | EditCo Bio secures access to Promega's technologies in licensing deal | ||
| 23.04. | FDA layoffs and priority review voucher programme's lapse disrupt rare disease pipeline | ||
| 23.04. | Boehringer to expand oncology presence with $572m Tessellate Bio deal | ||
| 23.04. | ConcertAI and Bayer to boost precision oncology with AI and ML insights | ||
| 23.04. | TNF and Renova Health use AI to identify patients for GLP-1 treatments | ||
| 22.04. | First two medicinal products to undergo EU joint clinical assessments announced | ||
| 22.04. | FSO vs FSP: One CRO highlights key considerations for your decision | ||
| 22.04. | Regeneron partners with Fujifilm to broaden manufacturing capacity |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .